Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance. 		Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist disclosure reporting period:   01/01/2025 - 06/30/2025
Lobbyist name Rachel Cottle Latham   
Business name Pharmaceutical Research and Manufacturers of America Corporation
Address 125 Washington Street    Suite 1
City, state, zip code Foxboro, MA 02035         
Country US
Agent type Both
Phone 508-698-4990
 
 
Operating Expenses
No operating expenses were filed for this disclosure reporting period.
 
Activities, Bill Numbers and Titles
Client: Pharmaceutical Research and Manufacturers of America Corporation
Total amount paid by client; lobbyist is unable to report compensation at activity level: $6,081.99
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 724 An Act promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 895 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Oppose $0.00 N/A
Senate Bill 2529 An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects. Oppose $0.00 N/A
Senate Bill 1583 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 N/A
Senate Bill 2540 An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects Oppose $0.00 N/A
Senate Bill 904 An Act to strengthen health spending accountability processes within the health policy commission and the center for health information and analysis Oppose $0.00 N/A
House Bill 1133 An Act relative to patient financial protection Support $0.00 N/A
Senate Bill 1405 An Act repealing the sunset date for drug stewardship Oppose $0.00 N/A
House Bill 1107 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
House Bill 1167 An Act to enact pharmacy benefit manager duties Support $0.00 N/A
House Bill 1296 An Act to protect 340B providers Oppose $0.00 N/A
Senate Bill 868 An Act enhancing health care market oversight and pharmaceutical access Oppose $0.00 N/A
House Bill 1234 An Act relative to pharmacy benefit managers Support $0.00 N/A
Senate Bill 819 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Oppose $0.00 N/A
House Bill 1334 An Act to enact pharmacy benefit manager duties Support $0.00 N/A
House Bill 1092 An Act to ensure affordable prescription medications through accountability standards Oppose $0.00 N/A
House Bill 1082 An Act to enact the pharmacy benefit manager compensation reform Support $0.00 N/A
House Bill 1274 An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program Oppose $0.00 N/A
House Bill 1 An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Oppose $0.00 N/A
Senate Bill 2035 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 N/A
House Bill 4000 An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Oppose $0.00 N/A
Executive Center for Health Information and Analysis (CHIA) Discussed Prescription Drug Pricing Neutral $0.00 N/A
House Bill 1101 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1246 An Act establishing a public health option Oppose $0.00 N/A
House Bill 1364 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 860 An Act establishing Medicare for all in Massachusetts Oppose $0.00 N/A
Senate Bill 698 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 875 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
No campaign contributions were filed for this disclosure reporting period.
Close this page
William Francis Galvin Secretary of the Commonwealth of Massachusetts
One Ashburton Place
Boston, MA   02108

1-800-392-6090
cis@sec.state.ma.us

Connect with Us

Terms and Conditions     Accessibility Statement